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Background: No definitive protocol has been introduced for treatment or prevention of chemotherapy induced 
mucositis. The aim of this study was to assess the additive effect of Persica and chlorhexidine on chemotherapy 
induced mucositis of children with hematomalignancies.
Material and Methods: This randomized clinical trial was performed on 44 children aged 6 to 12 years who were 
under a similar maintenance chemotherapy protocol for their hematomalignancies. The clinician instructed oral 
hygiene cares to the patients and their parents and the severity of the mucositis and oral health status of patients 
were evaluated according to Oral Assessment Guide index. Then, the patients were randomly assigned to one of 
two experimental groups and were instructed to rinse either with Persica oral drops or normal saline, twice a day 
for two weeks. Subsequently, the patients in both groups were educated to rinse with chlorhexidine for 30 seconds 
and avoid eating for an hour. Second and third oral examinations were performed on the 8th and 15th day using the 
same questionnaire.
Results: Comparing severity of mucositis and oral health status of patients did not show any significant difference 
between treatment groups in either of examination sessions (p>0.05). However, both treatment groups showed sta-
tistically significant oral health improvement, in terms of mucositis, plaque accumulation and gingival condition, 
in 14 days following mouthrinses administration (p<0.05).
Conclusions: Both mouth-rinse combinations were effective on mucositis, plaque and gingival status of children 
receiving chemotherapy. However, Persica does not seem to pose additional effect on chlorhexidine in decreasing 
severity of chemotherapy induced mucositis.
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Introduction
Cancer is the third leading cause of death in Iran. Leu-
kemia, lymphoma and CNS tumors have been shown to 
be the most common childhood malignancies in Iran (1, 
2). While cancer treatment, including chemotherapy and 
radiotherapy, increases survival rate of cancer patients, 
these modalities might potentially cause some trouble-
some and debilitating oral complications. Oral mani-
festations in children receiving chemotherapy has been 
reported to include mucositis and erythema, dysgeusia, 
gingivitis, gingival enlargement, lip cracking, dry mou-
th, coated tongue, infectious diseases, caries, periodonti-
tis, cheilitis, etc (3-5).
One of the most common adverse effects of chemothera-
peutic agents is mucositis (5). A wide range of incidence 
rate has been frequently mentioned for chemotherapy 
induced mucositis. However, as various chemotherapy 
protocols is practiced in different care centers and stu-
dies, it is not practical to predict the incidence rate of 
mucositis in each chemotherapy regimen. Therefore, it 
seems essential to determine its incidence rate in diffe-
rent chemotherapy protocols and each of the phase of 
treatment including induction, consolidation and main-
tenance phases.
As chemotherapeutic drugs target rapidly dividing epi-
thelial cells, mucositis tends to be more common in pe-
diatric population, with an incidence rate of up to 45%. 
Furthermore, oral mucositis has shown more rapid hea-
ling process in children in comparison to adult popula-
tion (6). Oral mucositis first presents as tingling sensa-
tion and erythematous patches in the oral cavity. During 
the course of mucositis, these lesions might eventually 
develop into infectious prone ulcerations, which in neu-
tropenic condition predispose the patient to septicemia. 
Mucositis might influence cancer patient’s nutritional 
status and quality of life and acts as a dose limiting to-
xicity in affected patients (7,8). Different method and 
therapeutic agents have been investigated for prevention 
and treatment of chemotherapy induced oral complica-
tions including mucositis consisting basic oral care pro-
tocol (brushing, flossing, dental visits before and during 
the treatment and usage of bland mouth-washes) anti-in-
flammatory agents, antimicrobial agents, cryotherapy, 
antiseptic agents, antibiotics, vitamins, cytokines, im-
mune regulator, herbal drugs, lasers, etc (9-11). Among 
these, effectiveness of chlorhexidine gluconate 0.12% 
and 0.2%, as antimicrobial and antiplaque compounds, 
have been widely investigated (12-17). Chlorhexidine 
has been shown to be both acceptable and well-tolerated 
in older than 6 year old children receiving chemothera-
py (18). Although no guideline has been published on 
the efficacy of chlorhexidine mouthwash for prevention 
or treatment of chemotherapy induced oral mucositis 
in both adults and children population receiving che-
motherapy, it seems to be beneficial, as it is effective in 
management of gingivitis and plaque accumulation, two 
common oral complication in these patients due to their 
poor oral hygiene (9).
Recently, the trend toward rinsing with Persica oral drop 
(Poursina co., Iran) has been increasing, especially in 
Iran. Persica is a herbal oral drop containing Salvado-
ra persica, Achillea millefolium (Yarrow) and Mentha 
spicatac (Mint) medicinal plants. This oral rinse can 
be swallowed safely and is not contraindicated during 
childhood and pregnancy. It has been proposed that as 
Salvadora persica has antibacterial, anti-inflammatory 
and antiulcer properties, it potentially decreases gingi-
val inflammation and microbial count of oral cavity and 
results in improved oral health status. Furthermore, mint 
and yarrow have been shown to pose anti-inflammatory 
and analgesic effects (19-20).
Oral assessment guide (OAG) seems to be an appropria-
te scale for assessing mucositis in both adult and pedia-
tric populations. In this regard, each of the 8 items of 
teeth, gingiva, buccal mucosa, lips, tongue, voice, swa-
llow and saliva, receive score 1 (normal condition), 2 
(mild changes without loss of the function or mucosal 
barrier) or 3 (severe changes with loss of the function 
or mucosal barrier). Sum of these subscales give an oral 
assessment score of 8 (healthy oral cavity) to 24 (21).
Due to the life threatening effects of chemotherapy indu-
ced mucositis including septicemia, it seems essential to 
provide an appropriate and effective oral care protocol 
for children under chemotherapy. Accordingly, the aim 
of this study was to assess the additive effect of persi-
ca on chlorhexidine mouthwash in oral health status of 




After approval by the local Ethical Committee of Sha-
hid Sadoughi University of Medical Sciences, a conve-
nient sample of 44 patients referred for chemotherapy 
was selected. Actually, based on the similar studies and 
considering the significance level of 0.05 and 80% sta-
tistical power of 80%, the sample size was 20 in each 
group. Enrolled in this study were 6-12 year old chil-
dren diagnosed with hematologic malignancies, who 
showed the ability to control their swallowing reflex. 
They should also lacked any history of asthma, allergic 
rhinitis and dermatitis or need for radiotherapy as part of 
their treatment protocol. Cases demonstrating sensitivity 
or infection following the application of any of the mou-
th-rinses or lacked sufficient cooperation in rinsing the 
mouth-washes were excluded from the study.
-Chemotherapy:
The antineoplastic treatment regimen of all participants 
was according to the BFM protocol consisting 6-Mer-
captopurine, Methotroxate, Vincristine and Prednisone.
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-Study design:
This was a single blinded randomized clinical trial study 
(IRCT2014060117935N1), in which the clinician who 
performed oral examination and measurements was 
blinded to the treatment groups. The participants could 
not be blinded due to the fact that persica is manufactu-
red as oral drop and has different taste in comparison to 
normal saline.
After obtaining written informed consent from their pa-
rents or legal guardian, patients were randomly assigned 
to one of the treatment groups according to free online 
software http://www.randomizer.org). Oral hygiene ins-
truction consisting tooth brushing after each meal and 
instructions on mouthwashes according to their corres-
ponding group were provided by the clinician to the pa-
tients and their parents. Then, the oral condition of the 
patients was recorded using a questionnaire consisting 
OAG index. The second and third oral examinations 
were performed on the 8th and 15th day using the same 
questionnaire. 
-Oral hygiene protocols: 
The patients were educated to brush their teeth and rinse 
either with Persica oral drops (Poursina co., Iran) (10 
drops in 15 ml water) or normal saline (15 ml), based 
on their corresponding group, twice a day (after break-
fast and dinner) for two weeks. Subsequently, patients 
in both groups were instructed to finally rinse with 15 
ml of chlorhexidine 0.2% (Shahr darou co., Iran) for 30 
seconds and avoid eating and drinking for an hour.
-Statistical analysis:
Data were analyzed by means of SPSS 16 software. 
Demographic and clinical data were compared by the 
Chi-square, Wilcoxon, T-test, paired T-test and Repea-
ted measures analysis. The criterion for statistical signi-
ficance was considered as P<0.05.
Results
Forty four children, suffering from ALL, were enrolled 
in this clinical trial study, 22 in each of the experimental 
groups. Four children were excluded from the study, 1 
due to development of fungal infection and 3 due to in-
sufficient cooperation in mouth-rinsing (Fig. 1).
According to analysis of the demographic data, no statis-
tically significant differences were observed between the 
experimental groups in relation to age and gender. The 
mean age of participants in the group I (cholorhexidin 
and persica) and group II (cholorhexidin and persica) was 
7.00±1.52 and 7.04±1.79, respectively. (T-test, P=0.451) 
female to male ratio of patients in the group I and II was 
respectively 11/9 and 7/13. (Chi-square, P=0.204).
Fig. 1: Flow diagram of the process through the phase of a randomized trial based on CONSORT statement.
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Table 1 consists the mean OAG score of participants of 
each group in the 3 time points. Furthermore, the mu-
cositis score of participants in each of the experimental 
groups according to OAG scale across the 3 time points 
is presented in Figure 2. The OAG score of the subjects 
tended to decrease significantly across the 3 time points.
(P<0.001) However, no significant group by time inte-
raction was observed (P=0.114). According to subsca-
les of OAG score, before interventions, the prevalence 
of plaque and debris, gingival inflammation, mucous 
membranes’ erythema and redness of the tongue were 
respectively 80, 77.5, 15 and 7.5 percent. Furthermore, 
the mean value of untreated carious teeth among parti-
cipants was 6.07.
In the detailed analysis of the distribution of participants 
according to each of 8 factors included in OAG score 
(Table 2), none of them showed significant difference 
between treatment groups in either of sessions (P>0.05).
Gingival status of patients of both experimental groups, 
according to classification of OAG score, tended to im-
prove significantly in 15 days following mouth-rinses 
administration. (Group I: Z=-2.449, P=0.014; Group 
II: Z=-2.000, P=0.046) Also as regards the status of the 
teeth, the plaque accumulation significantly decreased 
after 2 weeks rinsing with either of mouthwash com-
binations. (Group I: Z=-2.972, P=0.003; Group II: Z=-
2.236, P=0.025).
Discussion
Children are especially prone to develop chemotherapy 
induced mucositis and its occurrence has been reported 
to be up to 45% in pediatric population (5-6).
In the present study, the patients’ demographic data in-
cluding age and sex did not show significant difference 
between two groups (P>0.05). In addition, the patients’ 
oral health status of the two groups had not statistically 
significant difference according to OAG index, which 
reflects patients’ oral health regarding condition of gin-
giva, mucous membrane and the teeth. All patients were 
also under the same chemotherapy regimen regarding 
the type and dosage of chemotherapeutic agents. 
Therefore, with respect to the similarity of the samples, 
any kind of difference between two groups after comple-
tion of the study can be judged as the result of prescribed 
oral protocols.
Persica mouthwash is an inexpensive Iranian herbal pro-
duct which is recently taken into consideration due to its 
anti-inflammatory and anti-plaque properties. It is noted 
that this oral drop is helpful in promoting oral hygiene 
and reducing plaque and gingival indices (22). Chlor-
Categories 













Voice 1.1 1.1 1.1 1.05 1 1.05
P value NS NS NS
Swallow 1.05 1 1 1.1 1 1.05
P value NS NS NS
Lips 1.2 1.1 1.15 1.2 1.15 1.05
P value NS NS NS
Tongue 1.1 1.5 1.2 1.35 1 1
P value NS NS NS
Saliva 1.35 1.3 1.2 1.2 1.25 1.2
P value NS NS NS
Mucous membrane 1.2 1.1 1.35 1.35 1.1 1.05
P value NS NS NS
Gingiva 2 2 1.85 1.9 1.7 1.8
P value NS NS NS
Teeth 2.25 2.35 1.9 2.05 1.65 2.1
P value NS NS NS
Table 1: Means and P-values for oral assessment categories of treatment groups in evaluation 
sessions.
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hexidine gluconate has also anti- plaque, antibacterial 
and antifungal effects, and while coagulating serum and 
salivary proteins forms a white membrane on the infla-
med tissues and consequently reduces the inflammation 
of oral mucous membranes. (16,23) Chlorhexidine is 
able to control gingivitis and is used frequently for re-
moving oral plaque and bacteria (22,24). In a recent sys-
tematic review it is noted that although it is not possible 
to give any advice about using chlorhexidine for treat-
ment or prevention of mucositis in the patients receiving 
chemotherapy, this mouthwash can be prescribed for 
treatment of gingivitis or helping for plaque control in 
these patients (9). However, in this study, prescribing 
chlorhexidine mouthwash instead of placebo in children 
under chemotherapy was based on ethical consideration 
as none of the children must be left without preventive 
protocol.
Furthermore, chlorhexidin has been frequently included 
in preventive protocols suggested in oral medicine lite-
rature. OAG index is the most appropriate scale for appl-
ying in clinical studies and also examining mucositis in 
children and its validity and reliability has been shown 
in children. It should be noted that the subscales which 
are examined in OAG index are not peculiar to mucosi-
Fig. 2: Mean oral mucositis score of the treatment groups from 1st to 15th day of investigation period.
          Day 1st day 8th day 15th day
Group I Group II Group I Group II Group I Group II
OAG score
(Mean±SD)
11.25 ± 2.20 11.00 ± 1.26 10.75 ± 1.52 11.20 ± 1.54 9.85 ±1.39 10.30 ±1.22
P value 0.661 0.358 0.367
Table 2: Mean values for the OAG scores in the 3 time points related to subject groups.
tis, in other words this index is an appropriate criterion 
for assessing the patients’ oral health status (25,26).
In the present study, difference of the patients’ oral heal-
th according to OAG index following the administration 
of oral care and mouthwash protocols was not signifi-
cant in none of the times. This shows that both protocols 
had similar effect on the reduction of oral mucositis in 
children.
It should be noted that in the present study, for homoge-
nization of the two groups in respect of using two mou-
thwashes, in control group in addition to chlorhexidine, 
normal salinewas prescribed as negative control of Per-
sica oral drops. It is noteworthy that normal saline is a 
bland and safe mouthwash that helps in the formation of 
granulation tissue and promotion of healing process. It 
is also economical, easily accessible with no serious side 
effects. Although, no positive impact is approved while 
using normal saline for controlling mucositis, this mou-
thwash is frequently included in prescribed protocols for 
promoting oral health of patients with or susceptible to 
mucositis and can be helpful for oral hygiene mainte-
nance and patient comfort. In fact, patients’ oral health 
can be promoted by following oral care protocols and 
using mouthwashes for moisturizing the oral cavity, re-
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moving debris and consequently reducing accumulation 
of dental plaque (9). These cases can be the reason for 
the lack of difference between two groups in respect of 
children’s oral health status. 
The present study is the first one that examines the ad-
ditive effect of Persica on chlorhexidine in mucositis of 
the patients receiving chemotherapy; therefore, the results 
of this study are not comparable to the results of the pre-
vious studies. According to the results of this study, OAG 
index of the children receiving chemotherapy in both 
groups has been decreased significantly after two weeks 
of performing oral care protocol including brushing and 
using mouthwashes, and so it represents the promotion 
of oral health status of the children participating in this 
study. However, after one week of prescribing oral care 
protocol no significant change was seen in OAG index of 
the two groups. It should be noted that although therapeu-
tic or preventive effect of oral care protocols and that of 
using chlorhexidine on mucositis of the patients receiving 
chemotherapy have been frequently examined (12-17), 
because of differences in the prescribed mouthwashes 
in each protocol, percent of chlorhexidine, frequency of 
rinsing with mouthwashes, chemotherapeutic agents, age 
range of the studied population, type of malignancy and 
small sample size in most studies, detailed comparisons 
between studies cannot be done.
In a study by Cheng et al., oral care protocol including 
tooth brushing, using normal saline solution and chlor-
hexidine%0.2 mouthwashes, compared with control 
group, was more effective in preventing mucositis in 
children (6). In the present study, using mouthwashes 
containing normal saline and chlorhexidine %0.2 signi-
ficantly contributed to reduction of mucositis in the po-
pulation under study. However, Cheng’s study attempted 
to prevent mucositis in the induction phase of chemo-
therapy and in the present study the patients were in the 
maintenance phase of chemotherapy and because of the 
high prevalence of mucositis among patients before in-
terventions, oral protocols were aimed to decrease the 
severity rather than prevention of mucositis.
In the study by Soares et al. in 2011, incidence rate of 
oral mucositis and microbial analysis of children with 
mucositis was examined with chlorhexidine %0.12 (17). 
The results of this study suggested that prophylactic use 
of chlorhexidine gluconate %0.12 is effective in redu-
cing the incidence of oral mucositis and oral pathogens 
in children with ALL. It should be noted that in the pre-
sent study, dose of chlorhexidine was %0.2 is used and 
due to the high prevalence of mucositis in both groups 
before the intervention, oral care protocol was for the 
treatment of mucositis.
Unlike the present study, in most studies on therapeutic 
or preventive effect of oral care protocols, patients’ oral 
health status according to OAG index during the first 5-7 
days after chemotherapy had been slightly increased and 
then had had decreasing trend (13,27). In most of these 
studies, the patients receiving chemotherapy were in the 
induction or intensification phase of chemotherapy; the-
refore, due to differences in the type and dosage of the 
prescribed chemotherapeutic drugs, the results of these 
studies are different from the results of the present study.
The results of this study showed that the amount of pla-
que accumulation and the patients’ gingival condition 
according to the subscales in OAG index, were signi-
ficantly improved in both groups after prescribing the 
mouthwashes.
The effect of chlorhexidine and Salvadora persica con-
taining mouthwashes on the dental plaque and gingival 
condition of otherwise healthy patientsis examined and 
compared in many studies (22,28,29,30). Actually, an-
ti-plaque and anti-inflammatory effects of Persica and 
chlorhexidine can be the reason for promoting the pa-
tients’ condition of teeth and gingiva and consequently 
promoting oral health status of the children receiving 
chemotherapy in the present study.
The results of this study represent high prevalence of 
dental caries, plaque and debris, and gingivitis in chil-
dren receiving chemotherapy. Therefore, it is suggested 
that the children receiving chemotherapy in all phases 
and their parents should be aware of possible oral side 
effects of chemotherapy, therapeutic or preventive me-
thod for these lesions and oral health care procedures. 
Moreover, high prevalence of untreated dental caries in 
patients under study signifies the importance of the need 
to assess oral and dental status patients before starting 
chemotherapy, because chronic pulpitis and periodonti-
tis may be the source of systemic infection during pe-
riods of myelosuppression and neutropenia.
In comparison to most of observational studies on che-
motherapy induced mucositis of children, the present 
interventional study had an innate limitation of small 
number of patients appropriate for attending the study. 
However, hospital as a curing center for children suffe-
ring from cancer has the best potential for performing 
this intervention. This innate limitation of the study im-
posed on our will to assess greater number of patients or 
extending the duration of intervention or observation in 
future studies.
Conclusions
Generally, the results of this study showed that both 
prescribed oral care protocols in children receiving 
chemotherapy contributes to promotion of their oral 
health status regarding mucositis, plaque accumulation 
and gingivitis. However, Persica oral drop did not show 
significant additive effect on chlorhexidine for reducing 
chemotherapy induced mucositis of children in our sam-
ple size. Therefore, to provide specific protocol for these 
patients, further studies are necessarily needed to over-
come limitations of the present study.
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